|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,056 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,067,561 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
786,589 |
|
|
Total
Value |
$65,006,411 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-34.0%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-04-12 |
474,994 |
2024-04-12 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
Director |
2023-11-07 |
7,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
846 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 34
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
IMUX |
Immunic Inc |
Director |
|
2001-04-23 |
4 |
B |
$12.00 |
$99,996 |
D/D |
8,333 |
8,333 |
2.39 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2005-09-01 |
4 |
AB |
$8.58 |
$38,588 |
D/D |
4,500 |
4,500 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2005-10-03 |
4 |
AB |
$8.51 |
$12,765 |
D/D |
1,500 |
6,000 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2005-10-06 |
4 |
AB |
$8.00 |
$4,000 |
D/D |
500 |
6,500 |
2.73 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2005-10-12 |
4 |
AB |
$7.00 |
$3,500 |
D/D |
500 |
6,500 |
2.73 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2005-10-12 |
4/A |
AB |
$7.00 |
$3,500 |
D/D |
500 |
7,000 |
2.73 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2005-11-01 |
4 |
AB |
$8.36 |
$12,550 |
D/D |
1,500 |
8,500 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
officerTitle |
|
2005-12-01 |
4 |
AB |
$9.89 |
$14,916 |
D/D |
1,500 |
10,000 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
officerTitle |
|
2005-12-12 |
4 |
B |
$10.21 |
$10,208 |
D/D |
1,000 |
11,000 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
officerTitle |
|
2006-01-03 |
4 |
B |
$10.76 |
$16,190 |
D/D |
1,500 |
12,500 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
officerTitle |
|
2006-02-01 |
4 |
AB |
$11.62 |
$17,500 |
D/D |
1,500 |
14,000 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2006-03-01 |
4 |
AB |
$12.96 |
$19,490 |
D/D |
1,500 |
15,500 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2006-04-03 |
4 |
AB |
$13.33 |
$20,019 |
D/D |
1,500 |
17,000 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2006-04-28 |
4 |
A |
$6.92 |
$23,393 |
D/D |
3,381 |
21,881 |
|
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2006-05-01 |
4 |
AB |
$12.55 |
$18,880 |
D/D |
1,500 |
18,500 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2006-05-08 |
4 |
B |
$12.78 |
$12,778 |
D/D |
1,000 |
22,881 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2006-05-18 |
4 |
B |
$12.00 |
$12,000 |
D/D |
1,000 |
23,881 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2006-06-01 |
4 |
AB |
$13.05 |
$19,575 |
D/D |
1,500 |
25,381 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2006-06-14 |
4 |
B |
$13.15 |
$33,090 |
D/D |
2,500 |
27,881 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2006-07-03 |
4 |
AB |
$14.44 |
$21,660 |
D/D |
1,500 |
29,381 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2006-08-01 |
4 |
AB |
$14.50 |
$21,750 |
D/D |
1,500 |
30,881 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2006-10-31 |
4 |
B |
$6.92 |
$19,103 |
D/D |
2,761 |
33,642 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-02-20 |
4 |
AS |
$16.96 |
$220,481 |
D/D |
(13,000) |
20,642 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-02-22 |
4 |
AS |
$18.40 |
$18,400 |
D/D |
(1,000) |
19,642 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-03-02 |
4 |
AS |
$16.44 |
$24,723 |
D/D |
(1,500) |
18,142 |
0 |
- |
|
846 Records found
|
|
Page 1 of 34 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|